DunedinPACE: A DNA methylation biomarker of the Pace of Aging

DW Belsky,A Caspi,DL Corcoran,K Sugden,R Poulton,L Arseneault,A Baccarelli,K Chamarti,X Gao,E Hannon,HL Harrington,R Houts,M Kothari,D Kwon,J Mill,J Schwartz,P Vokonas,C Wang,B Williams,TE Moffitt
DOI: https://doi.org/10.1101/2021.08.30.21262858
2021-01-01
Abstract:Measures to quantify changes in the pace of biological aging in response to intervention are needed to evaluate geroprotective interventions for humans. We used data from the Dunedin Study 1972-3 birth cohort tracking within-individual decline in 19 indicators of organ-system integrity across four time points spanning two decades to model Pace of Aging. We distilled this two-decade Pace of Aging into a single-time-point DNA-methylation blood-test using elastic-net regression and a DNA-methylation dataset restricted to exclude probes with low test-retest reliability. We evaluated the resulting measure, named DunedinPACE, in five additional datasets. DunedinPACE showed high test-retest reliability, was associated with morbidity, disability, and mortality, and indicated faster aging in young adults with childhood adversity. DunedinPACE effect-sizes were similar to GrimAge Clock effect-sizes. In analysis of morbidity, disability, and mortality, DunedinPACE and added incremental prediction beyond GrimAge. DunedinPACE is a novel blood biomarker of the pace of aging for gerontology and geroscience.
What problem does this paper attempt to address?